About Click Therapeutics Clickotine
Clickotine is a non-prescription smoking cessation program from Click Therapeutics. Over 8 weeks the app sets a quit plan, sends personalized messages, offers breathing exercises and distractions for cravings, tracks progress and, in its program version, includes nicotine replacement therapy (patch, gum or lozenge). It is offered to members of sponsoring programs, such as employers and the youturn platform; the app listing says program members should download it. Click's focus has shifted to prescription digital therapeutics. The main published study is a 2017 single-arm trial of 416 smokers; no randomized trial has been published.